Skip to main content
SP5007,674.37+0.43%DOW53,277.01+0.98%NASDAQ26,180.46+0.43%BTC$77,812.00+5.53%ETH$2,513.75+7.22%GOLD$4,661.60+1.97%OIL$86.64-0.22%
Smart Investors Daily
Sign InSign Up Free
FR

NASDAQ · FREQ

Frequency Therapeutics, Inc.

Healthcare · Biotechnology

$0.30

Up+$0.01 (+4.76%)

Updated Aug 23, 2026, 12:47 AM

SID Score

—

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
10.94M
P/E ratio
-0.81
Dividend yield
0.00%
52-week range
— – —
Volume
309.16K
Avg. volume
135.08K

Price performance

FREQ price history

1M range · 0 trading sessions · Daily adjusted prices

FREQ does not have enough price history for the selected period.

Data unavailable

The requested market data was not found.

Latest FREQ news

The latest Smart Investors Daily articles mentioning FREQ.

Stock researchCompany · Overview

FREQ research

Overview

Company profile and research snapshot.

Company profile

Frequency Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapeutics to activate a person's innate regenerative potential to restore function. Its Progenitor Cell Activation approach uses small molecules and activate progenitor cells within the body to create functional tissue. The company's lead product candidate is FX-322, which is in Phase IIa clinical trial to treat the underlying cause of sensorineural hearing loss. It is also developing medicines for patients across a range of degenerative conditions, including multiple sclerosis, and diseases of the muscle, gastrointestinal tract, skin, and bone. The company has a license and collaboration agreement with Astellas Pharma Inc. for the development and commercialization of FX-322, as well as collaboration and licensing agreements with Massachusetts Eye and Ear, the Massachusetts Institute of Technology, The Scripps Research Institute, and Cambridge Enterprises Limited. Frequency Therapeutics, Inc. was incorporated in 2014 and is headquartered in Lexington, Massachusetts.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
$1.40
Implied upside
—
Analysts
—
FREQ recent ratings
DateFirmRatingTarget
Sep 26, 2023BairdNeutral—
Feb 15, 2023Chardan CapitalNeutral—
Feb 14, 2023OppenheimerPerform—
Feb 14, 2023BairdOutperform—
Dec 8, 2022Chardan CapitalBuy—
Open full forecast

News briefing

No generated briefing is available yet.

Benzinga · Sep 26, 2023

DraftKings To Rally Around 35%? Here Are 10 Other Analyst Forecasts For Tuesday

Berenberg cut the price target for American Airlines Group Inc. (NASDAQ: AAL) from $26 to $23. Berenberg analyst Adrian Yanoshik maintained an Outperform rating. American Airlines shares fell 0.4% to $12.86 in pre-market trading. Barclays slashed IHS Holding Limited (NYSE: IHS) price target from $11.5 to $9.5. Barclays analyst Maurice Patrick maintained an Overweight rating. IHS shares rose 0.6% to close at $5.17 on Monday. Jefferies slashed the price target for Nordson Corporation (NASDAQ: NDSN) from $260 to $240. Jefferies analyst Saree Boroditsky downgraded the stock from Buy to Hold. Nordson shares fell 1.1% to $221.85 in pre-market trading. Wells Fargo lowered the price target for Olin Corporation (NYSE: OLN) from $65 to $50. Wells Fargo analyst Michael Sison downgraded ...

Zacks Investment Research · Jul 17, 2023

Frequency (FREQ) Up 77% on Merger Deal With Korro Bio

Post-merger, Frequency (FREQ) focuses on advancing RNA editing programs. This combined entity is set to operate under the name Korro Bio, which will apply to trade on the NASDAQ under the ticker symbol KRRO.

PennyStocks · Jul 15, 2023

Are Analyst Opinions Important to Trading Penny Stocks?

Are analyst opinions important to buying and selling penny stocks The post Are Analyst Opinions Important to Trading Penny Stocks? appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Benzinga · Feb 13, 2023

Dow Gains Over 300 Points; S&P 500 Up 1%

U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining over 300 points on Monday. The Dow traded up 1.01% to 34,211.29 while the NASDAQ rose 1.52% to 11,896.33. The S&P 500 also rose, gaining, 1.07% to 4,134.24. Check This Out: Top 5 Health Care Stocks That Could Blast Off This Month   Leading and Lagging Sectors Information technology shares rose by 1.9% on Monday. Meanwhile, top gainers in the sector included Fastly, Inc. (NYSE: FSLY), up 28%, and Pagaya Technologies Ltd. (NASDAQ: PGY), up 16%. In trading on Monday, energy shares fell by 0.3%.   Top Headline TreeHouse Foods Inc (NYSE: THS) reported mixed results for its fourth quarter. The company posted quarterly sales growth of 22% year-on-year to $996.20 million, missing the consensus of $1.02 billion. Adjusted EPS of $0.98 beat the analyst consensus of $0.92.   Equities Trading UP Ocular Therapeutix, Inc. (NASDAQ: OCUL) shares shot up 40% to $5.42 after the company announced interim 10-month data from an ongoing U.S. Phase 1 clinical trial evaluating OTX-TKI for the treatment of wet AMD. Shares of Top Ships Inc. (NASDAQ: ...

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By